Publications

Detailed Information

Iodixanol vs ioxaglate for preventing contrast nephropathy: who is winner?

DC Field Value Language
dc.contributor.authorJo, S-H-
dc.contributor.authorKoo, B-K-
dc.contributor.authorYoun, T-J-
dc.contributor.authorKim, H-S-
dc.date.accessioned2009-12-29T07:12:46Z-
dc.date.available2009-12-29T07:12:46Z-
dc.date.issued2007-
dc.identifier.citationKidney Int 2007; 71: 828-829en
dc.identifier.issn0085-2538 (Print)-
dc.identifier.urihttp://www.nature.com/ki/journal/v71/n8/abs/5002211a.html-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17429424-
dc.identifier.urihttps://hdl.handle.net/10371/23160-
dc.language.isoen-
dc.publisherNature Publishing Groupen
dc.subjectContrast Media/*adverse effectsen
dc.subjectHumansen
dc.subjectIoxaglic Acid/*adverse effectsen
dc.subjectKidney Failure/*chemically induceden
dc.subjectResearch Designen
dc.subjectRisk Factorsen
dc.subjectTriiodobenzoic Acids/*adverse effectsen
dc.titleIodixanol vs ioxaglate for preventing contrast nephropathy: who is winner?en
dc.typeArticleen
dc.identifier.doi10.1038/sj.ki.5002211-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share